Name	TYPE	UNII	Display Name
(-)-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)CYTOSINE	sys	2T8Q726O95	LAMIVUDINE
2(1H)-PYRIMIDINONE, 4-AMINO-1-(2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)-, (2R-CIS)-	cn	2T8Q726O95	LAMIVUDINE
3TC	cd	2T8Q726O95	LAMIVUDINE
4-AMINO-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE [WHO-IP]	sys	2T8Q726O95	LAMIVUDINE
BCH 189, (-)-	cd	2T8Q726O95	LAMIVUDINE
COMBIVIR COMPONENT LAMIVUDINE	cn	2T8Q726O95	LAMIVUDINE
DELSTRIGO COMPONENT LAMIVUDINE	bn	2T8Q726O95	LAMIVUDINE
EMTRICITABINE IMPURITY C [WHO-IP]	cn	2T8Q726O95	LAMIVUDINE
EPIVIR	bn	2T8Q726O95	LAMIVUDINE
EPZICOM COMPONENT LAMIVUDINE	cn	2T8Q726O95	LAMIVUDINE
GR-109714X	cd	2T8Q726O95	LAMIVUDINE
GR109714X	cd	2T8Q726O95	LAMIVUDINE
KIVEXA COMPONENT LAMIVUDINE	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE TEVA	bn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE TEVA PHARMA B.V.	bn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [EMA EPAR]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [EP IMPURITY]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [EP MONOGRAPH]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [HSDB]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [JAN]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [MART.]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [MI]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [ORANGE BOOK]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [USAN]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [USP MONOGRAPH]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [USP-RS]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [VANDF]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [WHO-IP]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE/ZIDOVUDINE TEVA COMPONENT LAMIVUDINE	bn	2T8Q726O95	LAMIVUDINE
LAMIVUDINUM [WHO-IP LATIN]	cn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE	of	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [WHO-DD]	cn	2T8Q726O95	LAMIVUDINE
NSC-760061	cd	2T8Q726O95	LAMIVUDINE
TEMIXYS COMPONENT LAMIVUDINE	cn	2T8Q726O95	LAMIVUDINE
TRIUMEQ COMPONENT LAMIVUDINE	bn	2T8Q726O95	LAMIVUDINE
TRIZIVIR COMPONENT LAMIVUDINE	bn	2T8Q726O95	LAMIVUDINE
VIROLAM	cn	2T8Q726O95	LAMIVUDINE
ZEFFIX	bn	2T8Q726O95	LAMIVUDINE
LAMIVUDINE [INN]	cn	2T8Q726O95	LAMIVUDINE
2(1H)-PYRIMIDINONE, 4-AMINO-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)-, REL-	sys	US4RZW252L	LAMIVUDINE, CIS-(+/-)-
2(1H)-PYRIMIDINONE, 4-AMINO-1-(2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)-, CIS-	sys	US4RZW252L	LAMIVUDINE, CIS-(+/-)-
2(1H)-PYRIMIDINONE, 4-AMINO-1-(2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)-, CIS-(+/-)-	sys	US4RZW252L	LAMIVUDINE, CIS-(+/-)-
BCH-189	cd	US4RZW252L	LAMIVUDINE, CIS-(+/-)-
LAMIVUDINE, CIS-(+/-)-	cn	US4RZW252L	LAMIVUDINE, CIS-(+/-)-
CIS(+/-)-2-HYDROXYMETHYL-5-(CYTOSIN-1-YL)-1,3-OXATHIOLANE	sys	US4RZW252L	LAMIVUDINE, CIS-(+/-)-
CIS-LAMIVUDINE	cn	US4RZW252L	LAMIVUDINE, CIS-(+/-)-
REL-4-AMINO-1-((2R,5S)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)-2(1H)-PYRIMIDINONE	sys	US4RZW252L	LAMIVUDINE, CIS-(+/-)-
LYNOZYFIC	bn	M3CPC50MZS	LINVOSELTAMAB
LINVOSELTAMAB-GCPT	of	M3CPC50MZS	LINVOSELTAMAB
HUMAN IGG4-BASED ANTI-CD3 X ANTI-BCMA BISPECIFIC MONOCLONAL ANTIBODY THAT BINDS TO CD3 AND BCMA	cn	M3CPC50MZS	LINVOSELTAMAB
LINVOSELTAMAB	of	M3CPC50MZS	LINVOSELTAMAB
LINVOSELTAMAB [USAN]	cn	M3CPC50MZS	LINVOSELTAMAB
LINVOSELTAMAB [WHO-DD]	cn	M3CPC50MZS	LINVOSELTAMAB
REGN-5458	cd	M3CPC50MZS	LINVOSELTAMAB
REGN5458	cd	M3CPC50MZS	LINVOSELTAMAB
LINVOSELTAMAB [INN]	cn	M3CPC50MZS	LINVOSELTAMAB
1-CYCLOPENTENE-1-CARBOXYLIC ACID, 2-(((3-FLUORO-3'-METHOXY(1,1'-BIPHENYL)-4-YL)AMINO)CARBONYL)-, CALCIUM SALT, HYDRATE (2:1:2)	sys	7N9V0U5X93	VIDOFLUDIMUS CALCIUM
DIVIDOFLUDIMUS CALCIUM DIHYDRATE	cn	7N9V0U5X93	VIDOFLUDIMUS CALCIUM
K566C6K4CJ	cd	7N9V0U5X93	VIDOFLUDIMUS CALCIUM
VIDOFLUDIMUS CALCIUM [USAN]	cn	7N9V0U5X93	VIDOFLUDIMUS CALCIUM
VIDOFLUDIMUS HEMICALCIUM MONOHYDRATE	cn	7N9V0U5X93	VIDOFLUDIMUS CALCIUM
VIDOFLUDIMUS CALCIUM	of	7N9V0U5X93	VIDOFLUDIMUS CALCIUM
1-CYCLOPENTENE-1-CARBOXYLIC ACID, 2-(((3-FLUORO-3'-METHOXY(1,1'-BIPHENYL)-4-YL)AMINO)CARBONYL)-, CALCIUM SALT (2:1)	sys	FW5VY7926X	VIDOFLUDIMUS CALCIUM ANHYDROUS
VIDOFLUDIMUS CALCIUM ANHYDROUS	cn	FW5VY7926X	VIDOFLUDIMUS CALCIUM ANHYDROUS
VIDOFLUDIMUS CALCIUM [WHO-DD]	cn	FW5VY7926X	VIDOFLUDIMUS CALCIUM ANHYDROUS
1-CYCLOPENTENE-1-CARBOXYLIC ACID, 2-(((3-FLUORO-3'-METHOXY(1,1'-BIPHENYL)-4-YL)AMINO)CARBONYL)-	cn	8Y1PJ3VG81	VIDOFLUDIMUS
4SC-101	cd	8Y1PJ3VG81	VIDOFLUDIMUS
IMU-838	cd	8Y1PJ3VG81	VIDOFLUDIMUS
NSC-717824	cd	8Y1PJ3VG81	VIDOFLUDIMUS
SC-12267	cd	8Y1PJ3VG81	VIDOFLUDIMUS
SC12267	cd	8Y1PJ3VG81	VIDOFLUDIMUS
VIDOFLUDIMUS	of	8Y1PJ3VG81	VIDOFLUDIMUS
VIDOFLUDIMUS [USAN]	cn	8Y1PJ3VG81	VIDOFLUDIMUS
VIDOFLUDIMUS [WHO-DD]	cn	8Y1PJ3VG81	VIDOFLUDIMUS
VIDOFLUDIMUS [INN]	cn	8Y1PJ3VG81	VIDOFLUDIMUS
2-HYDROXYBENZENECARBOXYLIC ACID	sys	O414PZ4LPZ	SALICYLIC ACID
2-HYDROXYBENZOIC ACID	sys	O414PZ4LPZ	SALICYLIC ACID
2-HYDROXYBENZOIC ACID [FHFI]	cn	O414PZ4LPZ	SALICYLIC ACID
ACETYLSALICYLIC ACID IMPURITY C [EP IMPURITY]	cn	O414PZ4LPZ	SALICYLIC ACID
ACIDUM SALICYLICUM [WHO-IP LATIN]	cn	O414PZ4LPZ	SALICYLIC ACID
CARBASALATE CALCIUM IMPURITY C [EP IMPURITY]	cn	O414PZ4LPZ	SALICYLIC ACID
COMPOUND W	bn	O414PZ4LPZ	SALICYLIC ACID
DL-LYSINE ACETYLSALICYLATE IMPURITY A [EP IMPURITY]	cn	O414PZ4LPZ	SALICYLIC ACID
DR. SCHOLL'S CALLUS REMOVERS	bn	O414PZ4LPZ	SALICYLIC ACID
FEMA NO. 3985	cd	O414PZ4LPZ	SALICYLIC ACID
K-557	cd	O414PZ4LPZ	SALICYLIC ACID
LAMIVUDINE IMPURITY C [EP IMPURITY]	cn	O414PZ4LPZ	SALICYLIC ACID
MESALAZINE IMPURITY H [EP IMPURITY]	cn	O414PZ4LPZ	SALICYLIC ACID
NSC-180	cd	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [EP IMPURITY]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [EP MONOGRAPH]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [GREEN BOOK]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [HSDB]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [JAN]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [MART.]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [MI]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [USP MONOGRAPH]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [USP-RS]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [USP]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [VANDF]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [WHO-IP]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLICUM ACIDUM	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLICUM ACIDUM [HPUS]	cn	O414PZ4LPZ	SALICYLIC ACID
SULFASALAZINE IMPURITY H [EP IMPURITY]	cn	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID	of	O414PZ4LPZ	SALICYLIC ACID
SALICYLIC ACID [WHO-DD]	cn	O414PZ4LPZ	SALICYLIC ACID
1-((4-(5-(3-CHLORO-4-(2-METHYLPROPYL)PHENYL)-1,2,4-OXADIAZOL-3-YL)PHENYL)METHYL)-4-((2-METHOXYETHOXY)METHYL)-4-PIPERIDINECARBOXYLIC ACID POTASSIUM SALT	sys	A00HE5JO7O	VIBOZILIMOD POTASSIUM
SCD-044 POTASSIUM	cd	A00HE5JO7O	VIBOZILIMOD POTASSIUM
VIBOZILIMOD POTASSIUM [USAN]	cn	A00HE5JO7O	VIBOZILIMOD POTASSIUM
VIBOZILIMOD POTASSIUM	of	A00HE5JO7O	VIBOZILIMOD POTASSIUM
4-PIPERIDINECARBOXYLIC ACID, 1-((4-(5-(3-CHLORO-4-(2-METHYLPROPYL)PHENYL)-1,2,4-OXADIAZOL-3-YL)PHENYL)METHYL)-4-((2-METHOXYETHOXY)METHYL)-, POTASSIUM SALT (1:1)	sys	A00HE5JO7O	VIBOZILIMOD POTASSIUM
1-((4-(5-(3-CHLORO-4-(2-METHYLPROPYL)PHENYL)-1,2,4-OXADIAZOL-3-YL)PHENYL)METHYL)-4-((2-METHOXYETHOXY)METHYL)PIPERIDINE-4-CARBOXYLIC ACID	sys	0GYJ8CJ1DE	VIBOZILIMOD
4-PIPERIDINECARBOXYLIC ACID, 1-((4-(5-(3-CHLORO-4-(2-METHYLPROPYL)PHENYL)-1,2,4-OXADIAZOL-3-YL)PHENYL)METHYL)-4-((2-METHOXYETHOXY)METHYL)-	sys	0GYJ8CJ1DE	VIBOZILIMOD
SCD-044	cd	0GYJ8CJ1DE	VIBOZILIMOD
VIBOZILIMOD [USAN]	cn	0GYJ8CJ1DE	VIBOZILIMOD
VIBOZILIMOD [WHO-DD]	cn	0GYJ8CJ1DE	VIBOZILIMOD
VIBOZILIMOD	of	0GYJ8CJ1DE	VIBOZILIMOD
VIBOZILIMOD [INN]	cn	0GYJ8CJ1DE	VIBOZILIMOD
AF-82422	cd	52V6AS6U0A	AMLENETUG
AMLENETUG [USAN]	cn	52V6AS6U0A	AMLENETUG
AMLENETUG	of	52V6AS6U0A	AMLENETUG
IMMUNOGLOBULIN G1 (DE-C-TERMINAL-LYSINE), ANTI-(HUMAN .ALPHA.-SYNUCLEIN) (HUMAN MONOCLONAL LU AF82422 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL LU AF82422 .KAPPA.-CHAIN, DIMER	cn	52V6AS6U0A	AMLENETUG
LU AF-82422	cd	52V6AS6U0A	AMLENETUG
LU AF82422	cd	52V6AS6U0A	AMLENETUG
LU AF82422 (HUMAN IGG1 MAB THAT RECOGNIZES ALL MAJOR SPECIES OF ALPHA-SYNUCLEIN)	cn	52V6AS6U0A	AMLENETUG
LUAF-82422	cd	52V6AS6U0A	AMLENETUG
LUAF82422	cd	52V6AS6U0A	AMLENETUG
AMLENETUG [INN]	cn	52V6AS6U0A	AMLENETUG
MMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS SNCA (SYNUCLEIN ALPHA, PARK1, PARK4, PARKINSON DISEASE (AUTOSOMAL DOMINANT, LEWY BODY) 4, SYNUCLEIN ALPHA (NON A4 COMPONENT OF AMYLOID PRECURSOR))), HOMO SAPIENS MONOCLONAL ANTIBODY	cn	52V6AS6U0A	AMLENETUG
ZOPAPOGENE IMADENOVEC [USAN]	cn	C525BYS7TP	ZOPAPOGENE IMADENOVEC
ZOPAPOGENE IMADENOVEC	of	C525BYS7TP	ZOPAPOGENE IMADENOVEC
ZOPAPOGENE IMADENOVEC [INN]	cn	C525BYS7TP	ZOPAPOGENE IMADENOVEC
ALLOGENEIC CARDIOSPHERE-DERIVED CELLS	cn	ZM7OCV7H6H	DERAMIOCEL
CAP 1002 [WHO-DD]	cn	ZM7OCV7H6H	DERAMIOCEL
CAP-1002	cd	ZM7OCV7H6H	DERAMIOCEL
CAP1002	cd	ZM7OCV7H6H	DERAMIOCEL
DERAMIOCEL [USAN]	cn	ZM7OCV7H6H	DERAMIOCEL
DERAMIOCEL	of	ZM7OCV7H6H	DERAMIOCEL
HUMAN ALLOGENEIC CARDIOSPHERE-DERIVED CELLS	cn	ZM7OCV7H6H	DERAMIOCEL
KL-610091	cd	CZU4MF5NCE	TIRUMOTECAN
KL610091	cd	CZU4MF5NCE	TIRUMOTECAN
SULFONYLPYRIMIDINE-POLYETHYLENEGLYCOL-LYSINEMETHANESULFONYL BELOTECAN TRIFLUOROACETATE SALT	cn	CZU4MF5NCE	TIRUMOTECAN
TIRUMOTECAN [USAN]	cn	CZU4MF5NCE	TIRUMOTECAN
TIRUMOTECAN	of	CZU4MF5NCE	TIRUMOTECAN
BELACABNAGENE FRANLEUCEL [USAN]	cn	JG828PW4NT	BELACABNAGENE FRANLEUCEL
BELACABNAGENE FRANLEUCEL	of	JG828PW4NT	BELACABNAGENE FRANLEUCEL
HUMAN PERIPHERAL BLOOD MONONUCLEAR CELL (PBMC)-DERIVED NATURAL KILLER (NK) CELLS TRANSDUCED WITH VIRAL VECTOR ENCODING A CD19-TARGETING CHIMERIC ANTIGEN RECEPTOR (CAR) AND MEMBRANE BOUND INTERLEUKIN-15 (MBIL-15)	cn	JG828PW4NT	BELACABNAGENE FRANLEUCEL
NKX-019	cd	JG828PW4NT	BELACABNAGENE FRANLEUCEL
NKX019	cd	JG828PW4NT	BELACABNAGENE FRANLEUCEL
BELACABNAGENE FRANLEUCEL [INN]	cn	JG828PW4NT	BELACABNAGENE FRANLEUCEL
AZIRKITUG [USAN]	cn	R6HJ7X69JZ	AZIRKITUG
AZIRKITUG	of	R6HJ7X69JZ	AZIRKITUG
IMMUNOGLOBULIN G1, ANTI-(HUMAN CC CHEMOKINE RECEPTOR CCR8) (HUMAN-RATTUS NORVEGICUS MONOCLONAL PR-1925514 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-RATTUS NORVEGICUS MONOCLONAL PR-1925514 .KAPPA.-CHAIN, DIMER	cn	R6HJ7X69JZ	AZIRKITUG
PR-1925514	cd	R6HJ7X69JZ	AZIRKITUG
PR1925514	cd	R6HJ7X69JZ	AZIRKITUG
AZIRKITUG [INN]	cn	R6HJ7X69JZ	AZIRKITUG
IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS CCR8 (C-C MOTIF CHEMOKINE RECEPTOR 8, CKR-L1, CDW198)), HUMANIZED MONOCLONAL ANTIBODY	cn	R6HJ7X69JZ	AZIRKITUG
KL-610091 FREE BASE	cd	8SWM0Z4ZEY	TIRUMOTECAN FREE BASE
KL610091 FREE BASE	cd	8SWM0Z4ZEY	TIRUMOTECAN FREE BASE
TIRUMOTECAN FREE BASE	cn	8SWM0Z4ZEY	TIRUMOTECAN FREE BASE
5'-(4-FLUOROPHENYL)-3'-ISOPROPYL-N-(4-(4-METHYLPIPERAZIN-1-YL)PHENYL)-1H,3'H-(2,4'-BIIMIDAZOLE)-4-CARBOXAMIDE ACETATE	sys	6X7X6H7YDC	RENTOSERTIB ACETATE
INS-018_055 ACETATE	cd	6X7X6H7YDC	RENTOSERTIB ACETATE
INS018_055 ACETATE	cd	6X7X6H7YDC	RENTOSERTIB ACETATE
RENTOSERTIB ACETATE [USAN]	cn	6X7X6H7YDC	RENTOSERTIB ACETATE
RENTOSERTIB ACETATE	of	6X7X6H7YDC	RENTOSERTIB ACETATE
(2,5'-BI-1H-IMIDAZOLE)-5-CARBOXAMIDE, 4'-(4-FLUOROPHENYL)-1'-(1-METHYLETHYL)-N-(4-(4-METHYL-1-PIPERAZINYL)PHENYL)-, ACETATE (1:1)	sys	6X7X6H7YDC	RENTOSERTIB ACETATE
5'-(4-FLUOROPHENYL)-3'-ISOPROPYL-N-(4-(4-METHYLPIPERAZIN-1-YL)PHENYL)-1H,3'H-(2,4'-BIIMIDAZOLE)-4-CARBOXAMIDE	sys	M9NU5G8WXY	RENTOSERTIB
INS-018_055	cd	M9NU5G8WXY	RENTOSERTIB
INS018_055	cd	M9NU5G8WXY	RENTOSERTIB
RENTOSERTIB [USAN]	cn	M9NU5G8WXY	RENTOSERTIB
RENTOSERTIB	of	M9NU5G8WXY	RENTOSERTIB
(2,5'-BI-1H-IMIDAZOLE)-5-CARBOXAMIDE, 4'-(4-FLUOROPHENYL)-1'-(1-METHYLETHYL)-N-(4-(4-METHYL-1-PIPERAZINYL)PHENYL)-	sys	M9NU5G8WXY	RENTOSERTIB
(1'S,6'R)-7-CHLORO-2',4-DIMETHOXY-6'-METHYL-6-(5-METHYL-1,3,4-OXADIAZOL-2-YL)SPIRO(BENZOFURAN-2(3H),1'-(2)CYCLOHEXENE)-3,4'-DIONE	sys	XZD8UGS9H9	FORVISIRVAT
DS-7830A	cd	XZD8UGS9H9	FORVISIRVAT
FORVISIRVAT [USAN]	cn	XZD8UGS9H9	FORVISIRVAT
SP-624	cd	XZD8UGS9H9	FORVISIRVAT
SP624	cd	XZD8UGS9H9	FORVISIRVAT
SPIRO(BENZOFURAN-2(3H),1'-(2)CYCLOHEXENE)-3,4'-DIONE, 7-CHLORO-2',4-DIMETHOXY-6'-METHYL-6-(5-METHYL-1,3,4-OXADIAZOL-2-YL)-, (1'S,6'R)-	sys	XZD8UGS9H9	FORVISIRVAT
FORVISIRVAT	of	XZD8UGS9H9	FORVISIRVAT
CRONEXITIDE LANOCIANINE [USAN]	cn	M48HCF27ZE	CRONEXITIDE LANOCIANINE
CRONEXITIDE LANOCIANINE	of	M48HCF27ZE	CRONEXITIDE LANOCIANINE
CYPATE-CYCLO(CYS-GLY-ARG-ASP-SER-PRO-CYS)-LYS-OH (LS301)	cn	M48HCF27ZE	CRONEXITIDE LANOCIANINE
CYPATE-D-CYSTEYL-L-GLYCYL-L-ARGINYL-L-ASPARTYL-L-SERYL-L-PROLYL-L-CYSTEYL-L-LYSINE CYCLIC (2->8)-DISULFIDE	cn	M48HCF27ZE	CRONEXITIDE LANOCIANINE
LS-301	cd	M48HCF27ZE	CRONEXITIDE LANOCIANINE
LS301-IT	cd	M48HCF27ZE	CRONEXITIDE LANOCIANINE
CRONEXITIDE LANOCIANINE ACETATE [USAN]	cn	4N2FKB9HWP	CRONEXITIDE LANOCIANINE ACETATE
CYPATE-D-CYSTEYL-L-GLYCYL-L-ARGINYL-L-ASPARTYL-L-SERYL-L-PROLYL-L-CYSTEYL-L-LYSINE CYCLIC (2->8)-DISULFIDE ACETATE	cn	4N2FKB9HWP	CRONEXITIDE LANOCIANINE ACETATE
LS-301 ACETATE	cd	4N2FKB9HWP	CRONEXITIDE LANOCIANINE ACETATE
LS301 ACETATE	cd	4N2FKB9HWP	CRONEXITIDE LANOCIANINE ACETATE
LS301-IT ACETATE	cd	4N2FKB9HWP	CRONEXITIDE LANOCIANINE ACETATE
CRONEXITIDE LANOCIANINE ACETATE	of	4N2FKB9HWP	CRONEXITIDE LANOCIANINE ACETATE
1-(2-BENZYLOXYETHYL)-4-PHENYLPIPERIDINE-4-CARBOXYLIC ACID ETHYL ESTER	sys	X0I74BAR02	BENZETHIDINE
ACSCN-9606	cn	X0I74BAR02	BENZETHIDINE
BENZETHIDIN	cn	X0I74BAR02	BENZETHIDINE
BENZETHIDINE	of	X0I74BAR02	BENZETHIDINE
IDS-NB-001	cd	X0I74BAR02	BENZETHIDINE
ISONIPECOTIC ACID, 1-(2-(BENZYLOXY)ETHYL)-4-PHENYL-, ETHYL ESTER	sys	X0I74BAR02	BENZETHIDINE
NIH 7574	cd	X0I74BAR02	BENZETHIDINE
NIH-7574	cd	X0I74BAR02	BENZETHIDINE
BENZETHIDINE [INN]	cn	X0I74BAR02	BENZETHIDINE
4-PIPERIDINECARBOXYLIC ACID, 4-PHENYL-1-(2-(PHENYLMETHOXY)ETHYL)-, ETHYL ESTER, HYDROBROMIDE (1:1)	sys	D86V1SX1U7	BENZETHIDINE HYDROBROMIDE
BENZETHIDINE HYDROBROMIDE	cn	D86V1SX1U7	BENZETHIDINE HYDROBROMIDE
1,4-DITHIANE-2,5-DIOL	sys	R4F79F1JB0	2,5-DIHYDROXY-1,4-DITHIANE
2,5-DIHYDROXY-1,4-DITHIANE [FHFI]	cn	R4F79F1JB0	2,5-DIHYDROXY-1,4-DITHIANE
2,5-DIHYDROXY-1,4-DITHIANE	sys	R4F79F1JB0	2,5-DIHYDROXY-1,4-DITHIANE
FEMA NO. 3826	cd	R4F79F1JB0	2,5-DIHYDROXY-1,4-DITHIANE
MERCAPTOACETALDEHYDE DIMER	cn	R4F79F1JB0	2,5-DIHYDROXY-1,4-DITHIANE
NSC-106280	cd	R4F79F1JB0	2,5-DIHYDROXY-1,4-DITHIANE
P-DIATHANE-2,5-DIOL	cn	R4F79F1JB0	2,5-DIHYDROXY-1,4-DITHIANE
(CARBOXYMETHYL)TRIMETHYLAMMONIUM	sys	3SCV180C9W	BETAINE
(TRIMETHYLAMMONIO)ACETATE	sys	3SCV180C9W	BETAINE
ABROMINE	cn	3SCV180C9W	BETAINE
BETAINE	of	3SCV180C9W	BETAINE
BETAINE ANHYDROUS	cn	3SCV180C9W	BETAINE
BETAINE ANHYDROUS [EMA EPAR]	cn	3SCV180C9W	BETAINE
BETAINE [FCC]	cn	3SCV180C9W	BETAINE
BETAINE [FHFI]	cn	3SCV180C9W	BETAINE
BETAINE [HSDB]	cn	3SCV180C9W	BETAINE
BETAINE [JAN]	cn	3SCV180C9W	BETAINE
BETAINE [MART.]	cn	3SCV180C9W	BETAINE
BETAINE [MI]	cn	3SCV180C9W	BETAINE
BETAINE [ORANGE BOOK]	cn	3SCV180C9W	BETAINE
BETAINE [USP-RS]	cn	3SCV180C9W	BETAINE
BETAINE [VANDF]	cn	3SCV180C9W	BETAINE
BETAINE, ANHYDROUS	cn	3SCV180C9W	BETAINE
BETAINE [WHO-DD]	cn	3SCV180C9W	BETAINE
FEMA NO. 4223	cd	3SCV180C9W	BETAINE
METHANAMINIUM, 1-CARBOXY-N,N,N-TRIMETHYL-	sys	3SCV180C9W	BETAINE
NSC-166511	cd	3SCV180C9W	BETAINE
TRIMETHYLGLYCINE	sys	3SCV180C9W	BETAINE
5107	cd	8680278NRH	CHLORAL BETAINE
CHLORAL BETAINE	of	8680278NRH	CHLORAL BETAINE
CHLORAL BETAINE [MI]	cn	8680278NRH	CHLORAL BETAINE
CHLORAL BETAINE [USAN]	cn	8680278NRH	CHLORAL BETAINE
CLORAL BETAINE	of	8680278NRH	CHLORAL BETAINE
CLORAL BETAINE [MART.]	cn	8680278NRH	CHLORAL BETAINE
CHLORAL HYDRATE BETAINE (1:1) COMPOUND	cn	8680278NRH	CHLORAL BETAINE
CLORAL BETAINE [WHO-DD]	cn	8680278NRH	CHLORAL BETAINE
METHANAMINIUM, 1-CARBOXY-N,N,N-TRIMETHYL-, HYDROXIDE, INNER SALT, COMPD. WITH 2,2,2-TRICHLORO-1,1-ETHANEDIOL (1:1)	cn	8680278NRH	CHLORAL BETAINE
CLORAL BETAINE [INN]	cn	8680278NRH	CHLORAL BETAINE
DEA NO. 2460	cd	8680278NRH	CHLORAL BETAINE
(5'-C-T-C-C-A-A-C-A-T-C-A-A-G-G-A-A-G-A-T-G-G-C-A-T-T-T-C-T-A-G), 5'-(P-(4-(4-((2-AMINO-2-OXOETHYL)(METHYL)AMINO)-6-((6-AMINOHEXYL)OXY)-1,3,5-TRIAZIN-2-YL)PIPERAZIN-1-YL))-N,N-DIMETHYLPHOSPHONAMIDATE	cn	3AR55D4G2D	ROSTUDIRSEN
ROSTUDIRSEN [USAN]	cn	3AR55D4G2D	ROSTUDIRSEN
ROSTUDIRSEN	of	3AR55D4G2D	ROSTUDIRSEN
ZELECIMENT ROSTUDIRSEN OLIGONUCLEOTID-LYSINE MODIFICATION	cn	3AR55D4G2D	ROSTUDIRSEN
3-PIPERIDINECARBOXAMIDE, 1-(CYCLOPROPYLMETHYL)-4-(((5-(2,4-DIFLUOROPHENYL)-3-ISOXAZOLYL)CARBONYL)AMINO)-N-(1-(2-PYRIMIDINYL)CYCLOPROPYL)-, (3S,4S)-	sys	122Q610M3R	CANVERIXIN
ACT-1004-1239	cd	122Q610M3R	CANVERIXIN
ACT-10041239	cd	122Q610M3R	CANVERIXIN
CANVERIXIN [USAN]	cn	122Q610M3R	CANVERIXIN
CANVERIXIN	of	122Q610M3R	CANVERIXIN
N-((3S,4S)-1-(CYCLOPROPYLMETHYL)-3-((1-(PYRIMIDIN-2-YL)CYCLOPROPYL)CARBAMOYL)PIPERIDIN-4-YL)-5-(2,4-DIFLUOROPHENYL)ISOXAZOLE-3-CARBOXAMIDE	sys	122Q610M3R	CANVERIXIN
ATYPICAL CHEMOKINE RECEPTOR 3	cn	YOU7UJ47HS	ATYPICAL CHEMOKINE RECEPTOR 3
CMKOR1	cn	YOU7UJ47HS	ATYPICAL CHEMOKINE RECEPTOR 3
CXCR7	cn	YOU7UJ47HS	ATYPICAL CHEMOKINE RECEPTOR 3
GPR159	cn	YOU7UJ47HS	ATYPICAL CHEMOKINE RECEPTOR 3
RDC1	cn	YOU7UJ47HS	ATYPICAL CHEMOKINE RECEPTOR 3
ALTPRP EXPRESSED PROTEIN	cn	72B45B3J7X	MAJOR PRION PROTEIN
ASCR	cn	72B45B3J7X	MAJOR PRION PROTEIN
CD230	cn	72B45B3J7X	MAJOR PRION PROTEIN
MAJOR PRION PROTEIN	cn	72B45B3J7X	MAJOR PRION PROTEIN
PRNP EXPRESSED PROTEIN	cn	72B45B3J7X	MAJOR PRION PROTEIN
PRP27-30	cn	72B45B3J7X	MAJOR PRION PROTEIN
PRP33-35C	cn	72B45B3J7X	MAJOR PRION PROTEIN
ERISONERSEN SODIUM [USAN]	cn	P3L77BNC89	ERISONERSEN SODIUM
ERISONERSEN SODIUM	of	P3L77BNC89	ERISONERSEN SODIUM
ION-717	cd	P3L77BNC89	ERISONERSEN SODIUM
ION717	cd	P3L77BNC89	ERISONERSEN SODIUM
ERISONERSEN [USAN]	cn	279R3CQ7DY	ERISONERSEN
ERISONERSEN	of	279R3CQ7DY	ERISONERSEN
ION-717 FREE ACID	cd	279R3CQ7DY	ERISONERSEN
ION717 FREE ACID	cd	279R3CQ7DY	ERISONERSEN
3-((4-(1-((1-(6-((((3S)-2,6-DIOXO-3-PIPERIDINYL)AMINO)CARBONYL)-3-PYRIDINYL)-4-PIPERIDINYL)METHYL)-4-PIPERIDINYL)PHENYL)AMINO)-5-((3R)-3-(3-METHYL-2-OXO-1-IMIDAZOLIDINYL)-1-PIPERIDINYL)-2-PYRAZINECARBOXAMIDE FUMARATE	sys	J878TB9MCH	BEXOBRUTIDEG FUMARATE
BEXOBRUTIDEG FUMARATE	cn	J878TB9MCH	BEXOBRUTIDEG FUMARATE
NX-5948 FUMARATE	cd	J878TB9MCH	BEXOBRUTIDEG FUMARATE
2-PYRAZINECARBOXAMIDE, 3-((4-(1-((1-(6-((((3S)-2,6-DIOXO-3-PIPERIDINYL)AMINO)CARBONYL)-3-PYRIDINYL)-4-PIPERIDINYL)METHYL)-4-PIPERIDINYL)PHENYL)AMINO)-5-((3R)-3-(3-METHYL-2-OXO-1-IMIDAZOLIDINYL)-1-PIPERIDINYL)-, (2E)-2-BUTENEDIOATE (1:1)	sys	J878TB9MCH	BEXOBRUTIDEG FUMARATE
2-PYRAZINECARBOXAMIDE, 3-((4-(1-((1-(6-((((3S)-2,6-DIOXO-3-PIPERIDINYL)AMINO)CARBONYL)-3-PYRIDINYL)-4-PIPERIDINYL)METHYL)-4-PIPERIDINYL)PHENYL)AMINO)-5-((3R)-3-(3-METHYL-2-OXO-1-IMIDAZOLIDINYL)-1-PIPERIDINYL)-	sys	HVD6HGW6JD	BEXOBRUTIDEG
3-((4-(1-((1-(6-((((3S)-2,6-DIOXO-3-PIPERIDINYL)AMINO)CARBONYL)-3-PYRIDINYL)-4-PIPERIDINYL)METHYL)-4-PIPERIDINYL)PHENYL)AMINO)-5-((3R)-3-(3-METHYL-2-OXO-1-IMIDAZOLIDINYL)-1-PIPERIDINYL)-2-PYRAZINECARBOXAMIDE	sys	HVD6HGW6JD	BEXOBRUTIDEG
BEXOBRUTIDEG [USAN]	cn	HVD6HGW6JD	BEXOBRUTIDEG
BTK-IN-24	cd	HVD6HGW6JD	BEXOBRUTIDEG
NX-5948	cd	HVD6HGW6JD	BEXOBRUTIDEG
BEXOBRUTIDEG	of	HVD6HGW6JD	BEXOBRUTIDEG
A-1770637.0	cd	L5ED24R87T	ADIZUTECAN
ADIZUTECAN [USAN]	cn	L5ED24R87T	ADIZUTECAN
ADIZUTECAN	of	L5ED24R87T	ADIZUTECAN
L-ALANINAMIDE, N-(2-BROMOACETYL)-L-VALYL-N-(3-((7S)-7-ETHYL-7,8,11,13-TETRAHYDRO-7-HYDROXY-8,11-DIOXO-10H-1,3-DIOXOLO(4,5-G)PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLIN-14-YL)BICYCLO(1.1.1)PENT-1-YL)-	sys	L5ED24R87T	ADIZUTECAN
AMG-761	cd	YI437801BE	MOGAMULIZUMAB
IMMUNOGLOBULIN G1, ANTI-(CC CHEMOKINE RECEPTOR CCR4) (HUMAN-MOUSE MONOCLONAL KW-0761 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL KW-0761 .KAPPA.-CHAIN, DIMER	cn	YI437801BE	MOGAMULIZUMAB
KM-8761	cd	YI437801BE	MOGAMULIZUMAB
KM8761	cd	YI437801BE	MOGAMULIZUMAB
KW-0761	cd	YI437801BE	MOGAMULIZUMAB
MOGAMULIZUMAB	of	YI437801BE	MOGAMULIZUMAB
MOGAMULIZUMAB (GENETICAL RECOMBINATION)	cn	YI437801BE	MOGAMULIZUMAB
MOGAMULIZUMAB (GENETICAL RECOMBINATION) [JAN]	cn	YI437801BE	MOGAMULIZUMAB
MOGAMULIZUMAB [JAN]	cn	YI437801BE	MOGAMULIZUMAB
MOGAMULIZUMAB [MI]	cn	YI437801BE	MOGAMULIZUMAB
MOGAMULIZUMAB [USAN]	cn	YI437801BE	MOGAMULIZUMAB
MOGAMULIZUMAB [WHO-DD]	cn	YI437801BE	MOGAMULIZUMAB
MOGAMULIZUMAB [INN]	cn	YI437801BE	MOGAMULIZUMAB
C-C CHEMOKINE RECEPTOR TYPE 4	cn	L2FP9BPP3S	C-C CHEMOKINE RECEPTOR TYPE 4
CCR4	cn	L2FP9BPP3S	C-C CHEMOKINE RECEPTOR TYPE 4
CD194	cn	L2FP9BPP3S	C-C CHEMOKINE RECEPTOR TYPE 4
CMKBR4	cn	L2FP9BPP3S	C-C CHEMOKINE RECEPTOR TYPE 4
K5-5	cn	L2FP9BPP3S	C-C CHEMOKINE RECEPTOR TYPE 4
(+/-)-TRANS-LAMIVUDINE	cn	77ANF82R6X	LAMIVUDINE, TRANS(+/-)-
2(1H)-PYRIMIDINONE, 4-AMINO-1-((2R,5R)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)-, REL-	sys	77ANF82R6X	LAMIVUDINE, TRANS(+/-)-
2(1H)-PYRIMIDINONE, 4-AMINO-1-(2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)-, TRANS-	sys	77ANF82R6X	LAMIVUDINE, TRANS(+/-)-
4-AMINO-1-((2RS,5RS)-2-(HYDROXYMETHYL)-1,3-OXATHIOLAN-5-YL)PYRIMIDIN-2(1H)-ONE	sys	77ANF82R6X	LAMIVUDINE, TRANS(+/-)-
LAMIVUDINE IMPURITY B [EP IMPURITY]	cn	77ANF82R6X	LAMIVUDINE, TRANS(+/-)-
LAMIVUDINE IMPURITY B [USP IMPURITY]	cn	77ANF82R6X	LAMIVUDINE, TRANS(+/-)-
LAMIVUDINE, (+/-)-TRANS-	cn	77ANF82R6X	LAMIVUDINE, TRANS(+/-)-
LAMIVUDINE, TRANS(+/-)-	cn	77ANF82R6X	LAMIVUDINE, TRANS(+/-)-
(+/-)-5-METHOXY-3,4-METHYLENEDIOXYAMPHETAMINE	sys	RG7FY73ZAA	MMDA
(+/-)-MMDA	cn	RG7FY73ZAA	MMDA
.BETA.-METHOXY-.ALPHA.-METHYL-4,5-(METHYLENEDIOXY)PHENETHYL AMINE	cn	RG7FY73ZAA	MMDA
1,3-BENZODIOXOLE-5-ETHANAMINE, 7-METHOXY-ALPHA-METHYL	sys	RG7FY73ZAA	MMDA
3-METHOXY-.ALPHA.-METHYL-4,5-(METHYLENEDIOXY)PHENETHYLAMINE	cn	RG7FY73ZAA	MMDA
3-METHOXY-ALPHA-METHYL-4,5-(METHYLENEDIOXY)PHENETHYLAMINE	cn	RG7FY73ZAA	MMDA
3-METHOXY-METHYLENEDIOXYAMPHETAMINE	sys	RG7FY73ZAA	MMDA
3-METHOXY-4,5-METHYLENEDIOXYAMPHETAMINE	sys	RG7FY73ZAA	MMDA
5-METHOXY-3,4-METHYLENEDIOXYAMPHETAMINE	sys	RG7FY73ZAA	MMDA
5-METHOXY-MDA	cn	RG7FY73ZAA	MMDA
BETA-METHOXY-ALPHA-METHYL-4,5-(METHYLENEDIOXY)PHENETHYL AMINE	sys	RG7FY73ZAA	MMDA
MMDA	cn	RG7FY73ZAA	MMDA
MMDA (PSYCHEDELIC)	cn	RG7FY73ZAA	MMDA
MMDA (DRUG)	cn	RG7FY73ZAA	MMDA
DEA NO. 7401	cd	RG7FY73ZAA	MMDA
A RECOMBINANT, SELF-COMPLEMENTARY NON-REPLICATING ADENO-ASSOCIATED VIRUS VECTOR WITH OLIG001 CAPSID (RAAV-OLIG-001) ENCODING CODON-OPTIMIZED HUMAN ASPARTOACYLASE (ASPA, ASP, ACY2)	cn	DM5GA58Q2Z	CIRACIGENE GOLPARVOVEC
CIRACIGENE GOLLPARVOVEC [USAN]	cn	DM5GA58Q2Z	CIRACIGENE GOLPARVOVEC
CIRACIGENE GOLPARVOVEC	of	DM5GA58Q2Z	CIRACIGENE GOLPARVOVEC
MYR-101	cd	DM5GA58Q2Z	CIRACIGENE GOLPARVOVEC
CIRACIGENE GOLPARVOVEC [INN]	cn	DM5GA58Q2Z	CIRACIGENE GOLPARVOVEC
(+/-)-.ALPHA.-METHYLPHENETHYLAMINE	sys	CK833KGX7E	AMPHETAMINE
(+/-)-DESOXYNOREPHEDRINE	cn	CK833KGX7E	AMPHETAMINE
.BETA.-AMINOPROPYLBENZENE	sys	CK833KGX7E	AMPHETAMINE
1-PHENYL-2-AMINOPROPANE	sys	CK833KGX7E	AMPHETAMINE
ADZENYS ER	bn	CK833KGX7E	AMPHETAMINE
ADZENYS XR-ODT	bn	CK833KGX7E	AMPHETAMINE
AMFETAMIN	bn	CK833KGX7E	AMPHETAMINE
AMFETAMINE	of	CK833KGX7E	AMPHETAMINE
AMFETAMINE [MART.]	cn	CK833KGX7E	AMPHETAMINE
AMPHETAMINE	sys	CK833KGX7E	AMPHETAMINE
AMPHETAMINE [HSDB]	cn	CK833KGX7E	AMPHETAMINE
AMPHETAMINE [MI]	cn	CK833KGX7E	AMPHETAMINE
AMPHETAMINE [ORANGE BOOK]	cn	CK833KGX7E	AMPHETAMINE
AMPHETAMINE [VANDF]	cn	CK833KGX7E	AMPHETAMINE
AMPHETAMINE, DL-	cn	CK833KGX7E	AMPHETAMINE
AMFETAMINE [WHO-DD]	cn	CK833KGX7E	AMPHETAMINE
BENZENEETHANAMINE, .ALPHA.-METHYL-, (+/-)-	sys	CK833KGX7E	AMPHETAMINE
DYANAVEL	bn	CK833KGX7E	AMPHETAMINE
MYDAYIS (MIXED SALTS OF A SINGLE ENTITY)	bn	CK833KGX7E	AMPHETAMINE
NOREPHEDRANE	cn	CK833KGX7E	AMPHETAMINE
NSC-27159	cd	CK833KGX7E	AMPHETAMINE
SELEGILINE HYDROCHLORIDE IMPURITY B [EP IMPURITY]	cn	CK833KGX7E	AMPHETAMINE
AMFETAMINE [INN]	cn	CK833KGX7E	AMPHETAMINE
DEA NO. 1100	cd	CK833KGX7E	AMPHETAMINE
L-SERINE, N-(1,29-DIOXO-4,7,10,13,16,19,22,25-OCTAOXA-28-AZATETRATETRACONT-1-YL)GLYCYLGLYCYL-D-TYROSYL-L-PHENYLALANYL-L-LEUCYL-L-PROLYL-D-SERYL-L-GLUTAMINYL-L-PHENYLALANYL-D-ALANYL-(3S)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBONYL-	sys	3GEY66X2W2	URCOSIMOD
OK-101	cd	3GEY66X2W2	URCOSIMOD
URCOSIMOD [USAN]	cn	3GEY66X2W2	URCOSIMOD
URCOSIMOD	of	3GEY66X2W2	URCOSIMOD
GRT-C901	cn	AJ42U9BVW4	LUTADENOVEC AUTOGENE
LUTADENOVEC AUTOGENE [USAN]	cn	AJ42U9BVW4	LUTADENOVEC AUTOGENE
LUTADENOVEC AUTOGENE	of	AJ42U9BVW4	LUTADENOVEC AUTOGENE
LUTADENOVEC AUTOGENE [INN]	cn	AJ42U9BVW4	LUTADENOVEC AUTOGENE
AKS-321D	cd	C6834VZA9A	INSULIN EFLIVET
INSULIN EFLIVET [USAN]	cn	C6834VZA9A	INSULIN EFLIVET
INSULIN (SYNTHETIC MUTEIN) FUSION PROTEIN WITH IMMUNOGLOBULIN GB (CANIS FAMILIARIS .GAMMA.B-CHAIN C REGION C-TERMINAL FRAGMENT MUTEIN), DIMER	cn	C6834VZA9A	INSULIN EFLIVET
INSULIN EFLIVET	of	C6834VZA9A	INSULIN EFLIVET
4-AP	cn	BH3B64OKL9	DALFAMPRIDINE
4-AMINOPYRIDINE	sys	BH3B64OKL9	DALFAMPRIDINE
4-PYRIDINAMINE	sys	BH3B64OKL9	DALFAMPRIDINE
AMPYRA	bn	BH3B64OKL9	DALFAMPRIDINE
DALFAMPRIDINE [HSDB]	cn	BH3B64OKL9	DALFAMPRIDINE
DALFAMPRIDINE [II]	cn	BH3B64OKL9	DALFAMPRIDINE
DALFAMPRIDINE [MI]	cn	BH3B64OKL9	DALFAMPRIDINE
DALFAMPRIDINE [ORANGE BOOK]	cn	BH3B64OKL9	DALFAMPRIDINE
DALFAMPRIDINE [USAN]	cn	BH3B64OKL9	DALFAMPRIDINE
DALFAMPRIDINE [USP MONOGRAPH]	cn	BH3B64OKL9	DALFAMPRIDINE
DALFAMPRIDINE [USP-RS]	cn	BH3B64OKL9	DALFAMPRIDINE
DALFAMPRIDINE [VANDF]	cn	BH3B64OKL9	DALFAMPRIDINE
DALFAMPRIDINE	of	BH3B64OKL9	DALFAMPRIDINE
EL-970	cd	BH3B64OKL9	DALFAMPRIDINE
FAMPRIDINE	of	BH3B64OKL9	DALFAMPRIDINE
FAMPRIDINE (4-AMINOPYRIDINE) [VANDF]	cn	BH3B64OKL9	DALFAMPRIDINE
FAMPRIDINE [EMA EPAR]	cn	BH3B64OKL9	DALFAMPRIDINE
FAMPRIDINE [JAN]	cn	BH3B64OKL9	DALFAMPRIDINE
FAMPRIDINE [MART.]	cn	BH3B64OKL9	DALFAMPRIDINE
FAMPRIDINE [VANDF]	cn	BH3B64OKL9	DALFAMPRIDINE
FAMPYRA	bn	BH3B64OKL9	DALFAMPRIDINE
FAMPRIDINE [WHO-DD]	cn	BH3B64OKL9	DALFAMPRIDINE
NSC-15041	cd	BH3B64OKL9	DALFAMPRIDINE
PYRIDIN-4-AMINE	sys	BH3B64OKL9	DALFAMPRIDINE
FAMPRIDINE [INN]	cn	BH3B64OKL9	DALFAMPRIDINE
1H-1,4-BENZODIAZEPINE-3-CARBOXYLIC ACID, 7-CHLORO-2,3-DIHYDRO-2-OXO-5-PHENYL-, POTASSIUM SALT COMPOUND WITH POTASSIUM HYDROXIDE (1:1)	sys	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
4306 CB	cd	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
4306-CB	cd	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
4306CB	cd	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
AB 35616	cd	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
ABBOTT-35616	cd	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CB 4306	cd	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CLORAZEPATE DIPOTASSIUM	of	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CLORAZEPATE DIPOTASSIUM CIV	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CLORAZEPATE DIPOTASSIUM CIV [USP-RS]	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CLORAZEPATE DIPOTASSIUM [JAN]	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CLORAZEPATE DIPOTASSIUM [ORANGE BOOK]	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CLORAZEPATE DIPOTASSIUM [USAN]	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CLORAZEPATE DIPOTASSIUM [USP MONOGRAPH]	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CLORAZEPATE DIPOTASSIUM [VANDF]	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CLORAZEPIC ACID DIPOTASSIUM SALT	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CLORAZEPIC ACID DIPOTASSIUM SALT [MI]	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CM 4306	cd	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
CLORAZEPATE DIPOTASSIUM [WHO-DD]	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
DIPOTASSIUM CLORAZEPATE	of	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
DIPOTASSIUM CLORAZEPATE [EP IMPURITY]	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
DIPOTASSIUM CLORAZEPATE [MART.]	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
GEN-XENE	bn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
POTASSIUM 7-CHLORO-2,3-DIHYDRO-2-OXO-5-PHENYL-1H-1,4-BENZODIAZEPINE-3-CARBOXYLATE COMPOUND WITH POTASSIUM HYDROXIDE (1:1)	sys	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
TR 19119	cd	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
TRANXENE	bn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
DIPOTASSIUM CLORAZEPATE [INN]	cn	63FN7G03XY	CLORAZEPATE DIPOTASSIUM
FENPROPOREX HYDROCHLORIDE, (-)-	cn	0581EU40J9	FENPROPOREX HYDROCHLORIDE, (R)-
FENPROPOREX HYDROCHLORIDE, (R)-	cn	0581EU40J9	FENPROPOREX HYDROCHLORIDE, (R)-
PROPIONITRILE, 3-((.ALPHA.-METHYLPHENETHYL)AMINO)-, MONOHYDROCHLORIDE, (-)-	sys	0581EU40J9	FENPROPOREX HYDROCHLORIDE, (R)-
FENPROPOREX HYDROCHLORIDE, (+)-	cn	8C8C0XU803	FENPROPOREX HYDROCHLORIDE, (S)-
FENPROPOREX HYDROCHLORIDE, (S)-	cn	8C8C0XU803	FENPROPOREX HYDROCHLORIDE, (S)-
PROPIONITRILE, 3-((.ALPHA.-METHYLPHENETHYL)AMINO)-, MONOHYDROCHLORIDE, (+)-	sys	8C8C0XU803	FENPROPOREX HYDROCHLORIDE, (S)-
(-)-N-CYANOETHYLAMPHETAMINE	sys	24GAY4MXL2	FENPROPOREX, (R)-
FENPROPOREX, (-)-	cn	24GAY4MXL2	FENPROPOREX, (R)-
FENPROPOREX, (R)-	cn	24GAY4MXL2	FENPROPOREX, (R)-
J264.765F	cd	24GAY4MXL2	FENPROPOREX, (R)-
PROPANENITRILE, 3-((1-METHYL-2-PHENYLETHYL)AMINO)-, (R)-	sys	24GAY4MXL2	FENPROPOREX, (R)-
(+)-N-CYANOETHYLAMPHETAMINE	sys	3URD5R3CW8	FENPROPOREX, (S)-
FENPROPOREX, (+)-	cn	3URD5R3CW8	FENPROPOREX, (S)-
FENPROPOREX, (S)-	cn	3URD5R3CW8	FENPROPOREX, (S)-
J264.766D	cd	3URD5R3CW8	FENPROPOREX, (S)-
PROPANENITRILE, 3-((1-METHYL-2-PHENYLETHYL)AMINO)-, (S)-	sys	3URD5R3CW8	FENPROPOREX, (S)-
(+/-)-3-(.ALPHA.-METHYLPHENETHYLAMINO)PROPIONITRILE HYDROCHLORIDE	sys	09PE91J6V6	FENPROPOREX HYDROCHLORIDE
(+/-)-N-2-CYANOETHYLAMPHETAMINE HYDROCHLORIDE	sys	09PE91J6V6	FENPROPOREX HYDROCHLORIDE
FENPROPOREX HCL	cn	09PE91J6V6	FENPROPOREX HYDROCHLORIDE
FENPROPOREX HYDROCHLORIDE	cn	09PE91J6V6	FENPROPOREX HYDROCHLORIDE
FENPROPOREX HYDROCHLORIDE [MART.]	cn	09PE91J6V6	FENPROPOREX HYDROCHLORIDE
FENPROPOREX HYDROCHLORIDE [MI]	cn	09PE91J6V6	FENPROPOREX HYDROCHLORIDE
FENPROPOREX HYDROCHLORIDE [WHO-DD]	cn	09PE91J6V6	FENPROPOREX HYDROCHLORIDE
GACILIN	bn	09PE91J6V6	FENPROPOREX HYDROCHLORIDE
N-2-CYANOETHYLAMPHETAMINE HYDROCHLORIDE	sys	09PE91J6V6	FENPROPOREX HYDROCHLORIDE
SOLVOLIP	bn	09PE91J6V6	FENPROPOREX HYDROCHLORIDE
BENZENEETHANAMINE, N-ETHYL-.ALPHA.-METHYL-, (.ALPHA.R)-	sys	B6E8U4IPLT	ETILAMFETAMINE, (R)-
ETILAMFETAMINE, (-)-	cn	B6E8U4IPLT	ETILAMFETAMINE, (R)-
ETILAMFETAMINE, (R)-	cn	B6E8U4IPLT	ETILAMFETAMINE, (R)-
PHENETHYLAMINE, N-ETHYL-.ALPHA.-METHYL-, (-)-	cn	B6E8U4IPLT	ETILAMFETAMINE, (R)-
BENZENEETHANAMINE, N-ETHYL-.ALPHA.-METHYL-, (.ALPHA.S)-	sys	N44633NPCV	ETILAMFETAMINE, (S)-
ETILAMFETAMINE, (+)-	cn	N44633NPCV	ETILAMFETAMINE, (S)-
ETILAMFETAMINE, (S)-	cn	N44633NPCV	ETILAMFETAMINE, (S)-
PHENETHYLAMINE, N-ETHYL-.ALPHA.-METHYL-, (+)-	cn	N44633NPCV	ETILAMFETAMINE, (S)-
ETHYLAMPHETAMINE	sys	022YON1XMX	ETILAMFETAMINE
ETILAMFETAMINE	of	022YON1XMX	ETILAMFETAMINE
ETHYLAMPHETAMINE [WHO-DD]	cn	022YON1XMX	ETILAMFETAMINE
N-ETHYL-.ALPHA.-METHYLPHENETHYLAMINE	sys	022YON1XMX	ETILAMFETAMINE
N-ETHYLAMPHETAMINE	sys	022YON1XMX	ETILAMFETAMINE
N-ETHYLAMPHETAMINE [MI]	cn	022YON1XMX	ETILAMFETAMINE
ETILAMFETAMINE [INN]	cn	022YON1XMX	ETILAMFETAMINE
